Zynerba Pharmaceuticals, Inc.

Alltranz Inc.

Buzzz Pharmaceuticals Limited

Jeffery Lynn Howard

Miroslaw Jerzy Golinski

Audra Lynn Stinchcomb

Dana Carmel Hammell

Stan Lee Banks

Guohua Li

Dand Carmel Hammell

Described herein are &#x394;-THC prodrugs, methods of making &#x394;-THC prodrugs, formulations comprising &#x394;-THC prodrugs and methods of using &#x394;-THC. One embodiment described herein relates to the transdermal administration of a &#x394;-THC prodrug for treating and preventing diseases and/or disorders.

Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same

Described herein are microneedle drug delivery systems comprising a pharmaceutical compositions comprising pharmaceutically active agents (e.g., cannabidiol and prodrugs of cannabidiol) and microneedle arrays suitable for local and systemic delivery of the active agent to a mammal. Also described herein are methods of using a microneedle transdermal or topical drug delivery systems comprising pharmaceutical compositions, comprising cannabidiol and prodrugs of cannabidiol, and microneedle arrays in the treatment disease, including pancreatitis and pancreatic cancer.

Use of cannabidiol prodrugs in topical and transdermal administration with microneedles

Described herein are abuse-resistant multi-layer transdermal patches comprising opioids and opioid prodrugs having a barrier layer located between the layer containing opioid or opioid prodrug and a layer containing an opioid antagonist or opioid antagonist prodrug.

Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists

Growing community of inventors

Lexington, KY, United States of America

Jeffery Lynn Howard